Onkologie. 2021:15(5):231-237 | DOI: 10.36290/xon.2021.044

Surgical treatment of brain metastases

Miloš Duba1, 2, Ivana Rošková1, 2, Andrej Mrlian1, 2, Pavel Fadrus1, 2, Václav Vybíhal1, 2, Tomáš Kazda3, Dagmar Al Tukmachi4, Jiří Šána4, Ondřej Hrdý5, 6, Jaroslav Duba5, 6, Martin Smrčka1, 2
1 Neurochirurgická klinika, FN Brno
2 Neurochirurgická klinika, Lékařská fakulta Masarykovy univerzity, Brno
3 Klinika radiační onkologie, Masarykův onkologický ústav Brno
4 Středoevropský technologický institut, Masarykova univerzita, Brno
5 Klinika anestezie, resuscitace a intenzivní medicíny, FN Brno
6 Klinika anestezie, resuscitace a intenzivní medicíny, Lékařská fakulta Masarykovy univerzity, Brno

With an annual incidence of 5/100,000, meningioma is the most common primary intracranial extraaxial tumor. It is usually a slow-growing tumor growing from arachnoid cells. In adults, they make up approximately 30% of all intracranial tumors. They are rare in children. Meningiomas occurs significantly more common in women. Most of the tumors are benign. The clinical manifestation depends on the location and size of the tumor. In therapy, surgical treatment is most important, the aim is total removal of the tumor, which often means a complete cure of the patient. The patient's prognosis is determined by the anatomical location, radicality of the resection and the histological type of the tumor according to the WHO classification. Some meningiomas, especially skull base meningiomas, which often compress or overgrow large vessels and cranial nerves, and infiltratively growing meningiomas, which often correspond to a histologically higher grade according to the WHO classification, are very difficult to remove. An important factor in the treatment of meningiomas is also the general condition and internal comorbidities of the patients. Another treatment modality is radiosurgery. Hormone therapy remains a rather experimental alternative.

Keywords: meningioma, incidence, diagnostics, surgical therapy, dispensarization.

Published: October 11, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Duba M, Rošková I, Mrlian A, Fadrus P, Vybíhal V, Kazda T, et al.. Surgical treatment of brain metastases. Onkologie. 2021;15(5):231-237. doi: 10.36290/xon.2021.044.
Download citation

References

  1. Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol 2010; 99(3): 307-314. Go to original source... Go to PubMed...
  2. Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S, McDermott MW, et al. Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 2011; 117(6): 1272-1278. Go to original source... Go to PubMed...
  3. Larjavaara S, Haapasalo H, Sankila R, Helén P, Auvinen A. Is the incidence of meningiomas underestimated? A regional survey. Br J Cancer 2008; 99(1): 182-184. Go to original source... Go to PubMed...
  4. Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J. Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 2015; 68(1): 25-28. Go to original source... Go to PubMed...
  5. Perrot Applanat M, Groyer Picard MT, Kujas M. Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir 2012; 115(1-2): 20-30. Go to original source... Go to PubMed...
  6. Sughrue ME, Kane AJ, Shangari G, Rutkowski MJ, McDermott MW, Berger MS, et al. The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg 2010; 113(5): 1029-1035. Go to original source... Go to PubMed...
  7. Pannullo SC, Fraser JF, Moliterno J, Cobb W, Stieg PE. Stereotactic radiosurgery: a meta analysis of current therapeutic applications in neuro oncologic disease. J Neurooncol 2016; 103(1): 1-17. Go to original source... Go to PubMed...
  8. Schul DB, Wolf S, Krammer MJ, Landscheidt JF, Tomasino A, Lumenta CB. Meningioma surgery in the elderly: outcome and validation of 2 proposed grading scores systems. Neurosurgery 2012; 70(3): 555-565. Go to original source... Go to PubMed...
  9. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957; 20(1): 22-39. Go to original source... Go to PubMed...
  10. Jung HW, Yoo H, Paek SH, Choi KS. Long term outcome and growth rate of subtotally resected petroclival meningiomas: experience with 38 cases. Neurosurgery 2000; 46(3): 567-574. Go to original source... Go to PubMed...
  11. Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH. Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 2000; 46(1): 657-661. Go to original source... Go to PubMed...
  12. Hsu DW, Pardo FS, Efird JT, Linggood RM, Hedley Whyte ET. Prognostic significance of proliferative indices in meningiomas. J Neuropathol Exp Neurol 1994; 53(3): 247-255. Go to original source... Go to PubMed...
  13. Kondziolka D, Niranjan A, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for meningiomas. Neurosurg Clin North Am 1999; 10(4): 317-325. Go to original source...
  14. Nutting C, Brada M, Brazil L, Sibtain A, Saran F, Westbury C, et al. Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg 1999; 90(5): 823-827. Go to original source... Go to PubMed...
  15. Debus J, Wuendrich M, Pirzkall A, Hoess A, Schlegel W, Zuna I et al. High efficacy of fractionated stereotactic radiotherapy of large base of skull meningiomas: long term results. J Clin Oncol 2001; 19(15): 547-553. Go to original source... Go to PubMed...
  16. Stafford SL, Pollock BE, Foote RL, Link MJ, Gorman DA, Schomberg PJ et al. Meningioma radiosurgery: tumor control, outcomes and complications among 190 consecutive patients. Neurosurgery 2001; 49(5): 1029-1037. Go to original source... Go to PubMed...
  17. Wang L, Shengpan L, Yan Z, Hongqi R et al. The biological and diagnostic roles of MicroRNAs in meningiomas. Rev Neurosci 2020; 31(7), 771-778. Go to original source... Go to PubMed...
  18. Slavik H, Balik V, Vrbkova J, et al. Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling Neurosug. 2020; 87(5): 1055-1063.
  19. Santacroce A, Walier M, Régis J, Liščák R, Motti E, Lindquist C, et al. Long term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4,565 patients. Neurosurg 2012; 70(1): 32-39. Go to original source... Go to PubMed...
  20. Kollová A, Liščák R, Šemnícká J, Simonová G, Vladyka V, Urgosík D, et al. Dlhodobé výsledky liečby meningeómov Leksellovým gama nožom. Cesk Slov Neurol N 2010; 106(4): 415-421.
  21. Kollová A, Liscák R, Novotný J jr, Vladyka V, Simonová G, Janouskova L. Gamma knife surgery for benign meningioma. J Neurosurg 2007; 107(2): 325-336. Go to original source... Go to PubMed...
  22. Nakamura M, Roser F, Michel J, Jacobs C, Samii M. The natural history of incidental meningiomas. Neurosurgery 2003; 53(1): 62-70. Go to original source... Go to PubMed...
  23. Lee JH. Meningiomas: Diagnosis, Treatment, and Outcome. 1st ed. London (UK): Springer Science & Business Media 2009.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.